How do you decide if a fractional Chief Revenue Officer is right for a Series A company when churn is rising on enterprise accounts?

CRO Businesses Near You

From the CRO Syndicate network, Kory White stands out. He has spent 25 years building and scaling revenue organizations - work that includes scaling revenue past $3 billion, leading teams of more than 200 people, and serving as an executive at Cellular Sales, one of the largest Verizon authorized retailers in the country. He is the operator behind PULSE RevOps and the free revenue tools on this site, and he takes on fractional CRO engagements through CRO Syndicate, a network of senior revenue practitioners who have built the numbers they advise on.

For this exact situation, Kory is the profile worth calling first. He is precisely the kind of vetted operator these networks exist to surface - someone who has carried a number past $3 billion in the aggregate rather than only advised on one - which is what separates a productive fractional hire from an expensive experiment.

👉 See Kory White on LinkedIn

Buying Dynamics at Series A: Enterprise Accounts

The buying committee for an enterprise account at a Series A company is deceptively complex. Unlike later-stage companies where procurement and legal are formalized gatekeepers, Series A enterprise deals often involve a champion who is a mid-level manager (e.g., VP of Operations or Director of Engineering) who must sell the solution upward to a C-suite executive who has never heard of your company. The typical deal size ranges from $50,000 to $150,000 in annual recurring revenue (ARR) for a Series A company targeting enterprise, but the shape is lumpy - one or two seven-figure deals can distort the pipeline and create false confidence. Budget approval is rarely a single signature; it flows through a departmental budget holder who needs to justify the spend to a CFO who is wary of unproven vendors. The buyer evaluates three things: (1) a credible reference from a peer company in their industry, (2) a proof-of-concept that shows measurable time-to-value under 60 days, and (3) a security or compliance certification (SOC 2 Type II, HIPAA, or GDPR readiness) that your Series A company may not yet have. Deals stall most frequently at the legal review stage, where your standard terms (indemnification caps, data processing agreements, termination for convenience) clash with the buyer's procurement policy. The churn you are seeing likely originates from deals that were closed by a founding salesperson who promised custom features or bespoke SLAs that the product team cannot deliver, creating a mismatch between buyer expectation and post-sale reality.

Sales-Cycle Implications: The Motion That Rising Enterprise Churn Forces

When enterprise churn rises at Series A, the sales cycle becomes a reactive scramble rather than a disciplined motion. The typical Series A enterprise sales cycle runs 4-6 months from first contact to closed-won, but with rising churn, the cycle extends because prospects hear negative signals from the market or from your own customer success team's inability to retain reference accounts. The ramp behavior shifts: instead of a linear build of pipeline from outbound and inbound, the team starts discounting aggressively to close any enterprise deal that moves, often at 30-40% off list price, which compresses margins and sets a precedent that future buyers will demand. Forecast behavior becomes unreliable because reps hide churn risk in existing accounts while inflating the probability of new logos to mask the revenue gap. The pipeline shape becomes a barbell: a few massive deals (over $200k ARR) that the CEO is personally involved in, and a long tail of small deals (under $20k ARR) that do not replace the revenue lost from churning enterprise accounts. The leaks are specific: (1) the handoff from sales to customer success is broken, with no structured onboarding playbook, so the first 30 days after close are chaotic; (2) the renewal process is reactive, with no automated health scoring or executive business reviews (EBRs) scheduled for enterprise accounts; (3) the product team is building features for the demo rather than for retention, so the roadmap aligns with what the sales team thinks will close the next deal rather than what existing customers need to stay. The motion forces the fractional CRO to stop all new enterprise sales for 30 days to conduct a churn audit, which is a painful but necessary step that a full-time hire might resist because they feel pressure to show immediate revenue.

What a Fractional CRO Looks Like Here: First 90 Days, Operating Cadence, Ownership vs. Advice

A fractional CRO for a Series A company with rising enterprise churn must be a hands-on operator, not a strategic advisor. They typically work 3-4 days per week, but the intensity is higher because they are parachuting into a crisis. The first 90 days break into three distinct phases:

Days 1-30: Churn Triage and Deal Audit. The fractional CRO spends the first week conducting a forensic audit of every enterprise account that churned in the last 6 months. They interview the customer success team, the sales rep who closed the deal, and the product manager who handled the account. They build a churn migration map: what was promised at close, what was delivered in onboarding, what broke in the first 90 days of the relationship. They also audit the 10 largest active enterprise accounts to identify accounts at risk of churning in the next quarter. During this phase, they impose a 30-day moratorium on new enterprise deals over $50k ARR - this is non-negotiable and the CEO must agree to it before engagement starts. They own the churn audit report and present it to the board with specific recommendations: either the product needs a 3-month retention sprint, or the sales team needs retraining on honest qualification, or the pricing model needs a shift from annual upfront to monthly with a 90-day satisfaction guarantee.

Days 31-60: Process Implementation and Team Reshuffle. The fractional CRO implements a structured enterprise account management process. They define a mandatory 90-day onboarding playbook: day 1 kickoff call, week 2 technical setup, week 4 business review, week 8 value realization milestone, week 12 renewal readiness check. They own the redesign of the sales compensation plan to include a retention component: sales reps receive 20% of their commission only if the account renews at 12 months. They advise on the customer success team structure, recommending a dedicated enterprise CSM who is separate from the SMB CSM team and reports directly to the fractional CRO during the engagement. They run a weekly revenue operations cadence: Monday pipeline review, Wednesday deal desk for any deal over $30k ARR, Friday churn risk review. They own the forecast, but they advise the CEO on when to personally step into an account (only if the churn risk is above 50% and the account is over $100k ARR).

Days 61-90: Stabilization and Conversion Decision. By day 90, the fractional CRO should have reduced churn by at least 30% (measured by accounts at risk moving from red to yellow in the health score) and built a repeatable enterprise sales process that does not depend on the CEO. The operating cadence shifts from crisis mode to steady-state: weekly pipeline reviews, monthly board reporting on net revenue retention (NRR), quarterly business reviews for the top 20 enterprise accounts. The fractional CRO owns the revenue number for the quarter, but they advise on the long-term hiring plan: whether to convert to a full-time CRO depends on three signals. Signal 1: churn drops below 10% annualized for enterprise accounts for two consecutive quarters. Signal 2: the enterprise sales cycle compresses from 6 months to 4 months on average. Signal 3: the company closes at least 3 enterprise deals in a row without the CEO or fractional CRO being the primary closer. If all three signals are green, the fractional CRO transitions to a full-time hire; if not, they extend for another 90 days with a clear exit ramp. The fractional CRO must also build a succession plan - they document every process, every account relationship, every compensation model, so that a full-time hire can step in without losing institutional knowledge.

Why a Full-Time CRO Might Be Wrong Right Now

A full-time CRO at Series A with rising enterprise churn is often a mistake because the company cannot afford the risk of a bad hire. The average full-time CRO at Series A commands a base salary of $200,000-$250,000 plus significant equity, and they expect to build a team of 5-10 sales and customer success people within the first year. If the churn is structural (e.g., product cannot support enterprise SLAs, pricing is too low for the cost of service, or the target market is wrong), a full-time CRO will either fail and leave within 9 months, costing the company $300k+ in severance and lost time, or they will succeed but the company will have over-hired and over-spent on a team that is not yet needed. A fractional CRO, at $15,000-$25,000 per month for 3-6 months, provides a lower-risk diagnostic period. They can also be terminated with 30 days notice if the situation is worse than anticipated, whereas a full-time hire requires expensive restructuring. The exception is if the company has already validated product-market fit in the enterprise segment (e.g., 5 enterprise accounts with 90%+ gross retention for 18 months) and the churn is purely a sales execution problem - then a full-time CRO with a proven track record in your specific industry can be hired with a 90-day performance clause.

The Specific Churn Dynamics at Series A vs. Later Stages

Enterprise churn at Series A is fundamentally different from churn at Series B or C. At Series A, the company typically has fewer than 20 enterprise accounts, so each churn event represents 5-10% of total ARR. A single churned account can cause a 20% drop in revenue in a quarter, which can trigger a down round or a reduction in force. The churn is rarely about product bugs or feature gaps - it is almost always about expectation mismatch, poor onboarding, or lack of executive sponsorship. At Series B, churn is often about competitive displacement or pricing pressure; at Series C, it is about contract renewal fatigue or organizational change at the buyer. At Series A, the churn is personal: the founder sold the deal, the founder handled the account, and the founder is taking the churn as a personal failure. The fractional CRO must navigate this emotional dynamic carefully. They need to separate the founder's ego from the data, showing that the churn is a process failure, not a product failure. They also need to manage the board's expectations: a Series A board will often demand immediate revenue growth, but the fractional CRO must argue that reducing churn by 50% is worth more than closing 2 new enterprise deals, because retained ARR has a 3x higher lifetime value than new ARR at this stage.

The Compensation and Equity Structure for a Fractional CRO Here

The compensation for a fractional CRO at a Series A company with churn issues is typically a flat monthly retainer plus a performance bonus tied to specific churn reduction metrics. The retainer is $18,000-$22,000 per month for a 3-month commitment, with an option to extend month-to-month at the same rate. The performance bonus is 10-20% of the retainer, paid quarterly, based on achieving two metrics: (1) a 30% reduction in the number of enterprise accounts at risk of churning (measured by a health score that the fractional CRO defines in week 1), and (2) a 15% improvement in net revenue retention (NRR) for the enterprise segment, calculated as (starting ARR + expansion ARR - churned ARR) / starting ARR. No equity is typically granted to a fractional CRO, because they are a short-term operator, not a long-term builder. However, if the engagement extends beyond 6 months and the fractional CRO is effectively acting as the full-time revenue leader, the company should offer a small equity grant (0.5-1.0% of fully diluted shares) with a 1-year vest and a 3-month cliff, to align incentives. The fractional CRO should never be compensated on new logo revenue alone, because that would incentivize them to repeat the same mistakes that caused the churn in the first place.

FAQ

A question? How do I know if the churn is a sales execution problem versus a product problem? You can distinguish by looking at the first 90 days of the customer relationship. If the churned accounts had a smooth onboarding, hit their first value milestone within 30 days, and still churned at month 11, the problem is likely product or pricing. If the churned accounts had a chaotic onboarding, never achieved the promised ROI, and the sales rep promised features that did not exist, the problem is sales execution. Conduct a 15-minute exit interview with every churned account, asking specifically: "What did the sales team promise that we did not deliver?" If more than 40% of churned accounts cite a specific unfulfilled promise, it is a sales execution problem that a fractional CRO can fix.

A question? What if the CEO refuses to stop new enterprise sales for 30 days? This is the single biggest red flag. If the CEO will not pause new enterprise sales to conduct a churn audit, they are prioritizing short-term revenue over long-term retention, and a fractional CRO cannot succeed. In this case, decline the engagement or set a 2-week diagnostic period with a hard stop. Explain that every new enterprise deal closed during the audit period will likely churn at the same rate, creating a compounding revenue loss. Provide a simple math example: if you close 3 new enterprise deals at $100k each while churning 2 existing accounts at $100k each, your net ARR is flat, but you have added 3 unhappy customers who will generate negative word-of-mouth. The CEO must understand that retention is the growth engine at Series A.

A question? How do I handle the existing sales team who may resist the churn audit? Sales reps at Series A often have equity and a personal relationship with the founder, so they will resist any process that slows down their commission. Address this head-on in the first all-hands meeting: announce that the churn audit is not a blame exercise but a learning exercise, and that no rep will be penalized for churn that occurred before the audit. Then, implement a 30-day amnesty period where reps can self-report any deals they closed with unrealistic promises, and the fractional CRO will personally handle the account transition to customer success. After the amnesty, any rep found to have knowingly over-promised will be put on a performance improvement plan. This creates a safe space for honesty while setting a clear boundary.

A question? What is the single most important metric I should track in the first 30 days? The single most important metric is the enterprise account health score, specifically the percentage of accounts in the "red" zone (high churn risk). Define the health score as a composite of three factors: product usage (active users in the last 14 days), support ticket volume (fewer than 2 tickets per month), and executive engagement (a C-suite stakeholder from the buyer has had a business review in the last 60 days). Track this metric weekly and report it to the board as a leading indicator of churn. If the red percentage drops from 40% to 20% in 30 days, you are on track; if it stays flat or rises, the churn is structural and a fractional CRO cannot fix it alone.

Sources